MACROGENICS, INC. Payments for Restructuring
MACROGENICS, INC. (MGNX) reported Payments for Restructuring of $298.00 thousand for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-07.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsForRestructuring · last filed 2018-05-07
- MACROGENICS, INC. payments for restructuring for the quarter ending 2018-03-31 was $298.00K, a 21.58% decline year-over-year.
- MACROGENICS, INC. payments for restructuring for the quarter ending 2017-09-30 was $405.00K.
- MACROGENICS, INC. payments for restructuring for the quarter ending 2017-06-30 was $391.00K.
- MACROGENICS, INC. payments for restructuring for the quarter ending 2017-03-31 was $380.00K.
| Period end | Payments for Restructuring 3 month | Payments for Restructuring 6 month | Payments for Restructuring 9 month |
|---|---|---|---|
| 2018-03-31 | $298.00K 10-Q · filed 2018-05-07 | ||
| 2017-09-30 | $405.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $796.00K derived: sum of 2 quarters · filed 2017-11-08 | $1.18M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $391.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | $771.00K 10-Q · filed 2017-08-02 | |
| 2017-03-31 | $380.00K 10-Q · filed 2017-05-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |